Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study

References (44)

1. Rush AJ, Thase ME, Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53(8):743–753. PubMed CrossRef
2. Keller MB, Lavori PW, Coryell W, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA. 1986;255(22):3138–3142. PubMed CrossRef
3. Coryell W, Keller M, Endicott J, et al. Bipolar II illness: course and outcome over a five-year period. Psychol Med. 1989;19(1):129–141. PubMed CrossRef
4. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry. 2003;53(8):640–648. PubMed CrossRef
5. Coplan JD, Gopinath S, Abdallah CG, et al. A neurobiological hypothesis of treatment-resistant depression: mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front Behav Neurosci. 2014;8:189. PubMed CrossRef
6. McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383–399. PubMed CrossRef
7. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63(12):1337–1344. PubMed CrossRef
8. Portella MJ, Puigdemont D, Álvarez E, et al. Update on deep brain stimulation for treatment-resistant depression. Curr Psychiatry Rev. 2012;8(3). CrossRef
9. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150–158. PubMed CrossRef
10. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–377. PubMed CrossRef
11. Lozano AM, Mayberg HS, Giacobbe P, et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461–467. PubMed CrossRef
12. Malone DA Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65(4):267–275. PubMed CrossRef
13. Bewernick BH, Kayser S, Sturm V, et al. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology. 2012;37(9):1975–1985. PubMed CrossRef
14. Zhao H, Zhang BL, Yang SJ, et al. The role of lateral habenula-dorsal raphe nucleus circuits in higher brain functions and psychiatric illness. Behav Brain Res. 2015;277:89–98. PubMed CrossRef
15. Lozano AM, Giacobbe P, Hamani C, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg. 2012;116(2):315–322. PubMed CrossRef
16. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–660. PubMed CrossRef
17. Puigdemont D, Pérez-Egea R, Portella MJ, et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol. 2012;15(1):121–133. PubMed CrossRef
18. Crowell AL, Riva-Posse P, Holtzheimer PE, et al. Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Am J Psychiatry. 2019;176(11):949–956. PubMed CrossRef
19. Thase ME, Rush AJ. When at first you don’t succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(suppl 13):23–29.
20. Bobes J, Bulbena A, Luque A, et al; Grupo de Validacion en Espanol de Escalas Psicometricas. Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depression [A comparative psyometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale. Med Clin (Barc). 2003;120(18):693–700. PubMed CrossRef
21. Aibar-Durán JÁ, Rodríguez Rodríguez R, de Diego Adeliño FJ, et al. Long-term results of deep brain stimulation for treatment-resistant depression: outcome analysis and correlation with lead position and electrical parameters. Neurosurgery. 2022;90(1):72–80. PubMed CrossRef
22. Puigdemont D, Portella M, Pérez-Egea R, et al. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. J Psychiatry Neurosci. 2015;40(4):224–231. PubMed CrossRef
23. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37. PubMed
24. Aas IH. Guidelines for rating Global Assessment of Functioning (GAF). Ann Gen Psychiatry. 2011;10(2):2–11. PubMed CrossRef
25. Kelley ME, Franco AR, Mayberg HS, et al. The Illness Density Index (IDI): a longitudinal measure of treatment efficacy. Clin Trials. 2012;9(5):596–604. PubMed CrossRef
26. Andersen P, Gill R. Cox’s regression model for counting processes: a large sample study. Ann Stat. 1982;10(4):1100–1120. CrossRef
27. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168(5):502–510. PubMed CrossRef
28. Holtzheimer PE, Husain MM, Lisanby SH, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry. 2017;4(11):839–849. PubMed CrossRef
29. Thomson CJ, Segrave RA, Fitzgerald PB, et al. “Nothing to lose, absolutely everything to gain”: patient and caregiver expectations and subjective outcomes of deep brain stimulation for treatment-resistant depression. Front Hum Neurosci. 2021;15:755276. PubMed CrossRef
30. de Haan S, Rietveld E, Stokhof M, et al. Effects of deep brain stimulation on the lived experience of obsessive-compulsive disorder patients: In-depth interviews with 18 Patients. PLoS One. 2015;10(8):e0135524. PubMed CrossRef
31. Baertschi M, Flores Alves Dos Santos J, Burkhard P, et al. The burden of normality as a model of psychosocial adjustment after deep brain stimulation for Parkinson’s disease: a systematic investigation. Neuropsychology. 2019;33(2):178–194. PubMed CrossRef
32. Sokero TP, Melartin TK, Rytsälä HJ, et al. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry. 2005;186(4):314–318. PubMed CrossRef
33. Jiménez E, Arias B, Mitjans M, et al. Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder. Acta Psychiatr Scand. 2016;133(4):266–276. PubMed CrossRef
34. Peroski MS, Chu MM, Doddi SR, et al. The safety of electroconvulsive therapy in patients with implanted deep brain stimulators: a review of the literature and case report. J ECT. 2019;35(2):84–90. PubMed CrossRef
35. Puigdemont D, Portella MJ, Molet J, Pérez V. Deep brain stimulation in treatment-resistant depressive disorders. Brain Res J. 2012;5(3–4).
36. McInerney SJ, McNeely HE, Geraci J, et al. Neurocognitive predictors of response in treatment resistant depression to subcallosal cingulate gyrus deep brain stimulation. Front Hum Neurosci. 2017;11:74. PubMed CrossRef
37. Saleh C, Fontaine D. Deep brain stimulation for psychiatric diseases: what are the risks? Curr Psychiatry Rep. 2015;17(5):33. PubMed CrossRef
38. Khaleeq T, Hasegawa H, Samuel M, et al. Fixed-life or rechargeable battery for deep brain stimulation: which do patients prefer? Neuromodulation. 2019;22(4):489–492. PubMed CrossRef
39. Timmermann L, Schüpbach M, Hertel F, et al. A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey. Eur Neurol. 2013;69(4):193–199. PubMed CrossRef
40. Holma KM, Haukka J, Suominen K, et al. Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder. Bipolar Disord. 2014;16(6):652–661. PubMed CrossRef
41. Gronemann FH, Jørgensen MB, Nordentoft M, et al. Treatment-resistant depression and risk of all-cause mortality and suicidality in Danish patients with major depression. J Psychiatr Res. 2021;135:197–202. PubMed CrossRef
42. Haglund A, Lysell H, Larsson H, et al. Suicide immediately after discharge from psychiatric inpatient care: a cohort study of nearly 2.9 million discharges. J Clin Psychiatry. 2019;80(2):18m12172. PubMed CrossRef
43. Mar-Barrutia L, Real E, Segalás C, et al. Deep brain stimulation for obsessive-compulsive disorder: a systematic review of worldwide experience after 20 years. World J Psychiatry. 2021;11(9):659–680. PubMed CrossRef
44. Lachin JM. Fallacies of last observation carried forward analyses. Clin Trials. 2016;13(2):161–168. PubMed CrossRef